Overall, these data confirm the importance of the PERK/EIF2A/ATF/CHOP pathway within smooth muscle cells, which drives VSMC apoptosis during AAA development, and that targeted inhibition of the PERK pathway can prevent AAA development. The gene discussed is DDIT3; the disease is triple-A syndrome.